Dashboard
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.33
- The company has been able to generate a Return on Equity (avg) of 1.91% signifying low profitability per unit of shareholders funds
Stock is technically in a Mildly Bearish range
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Trading & Distributors
INR 210 Cr (Micro Cap)
11.00
11
0.00%
0.19
3.34%
0.39
Total Returns (Price + Dividend) 
Vikas Lifecare for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Vikas Lifecare Ltd is Rated Strong Sell
Vikas Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 July 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 November 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
Vikas Lifecare Ltd is Rated Strong Sell
Vikas Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 July 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 16 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Vikas Lifecare Ltd is Rated Strong Sell
Vikas Lifecare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 July 2024. However, the analysis and financial metrics presented here reflect the stock’s current position as of 05 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More Announcements 
Closure of Trading Window
26-Sep-2026 | Source : BSEIntimation of Trading Window closure
Intimation Of Approval For Extension Of Time For Holding Annual General Meeting (AGM) For The Financial Year Ended March 31 2026
17-Sep-2026 | Source : BSEIntimation of approval for extension of time for holding Annual General Meeting (AGM) for the financial year ended March 31 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Vikas Lifecare Ltd has announced 4:21 rights issue, ex-date: 29 Oct 21
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
0.0258
Held by 0 Schemes
Held by 10 FIIs (0.26%)
Vikas Garg (13.1%)
None
79.34%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 73.78% vs -31.35% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 242.31% vs 75.44% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'24
Growth in half year ended Sep 2024 is 5.60% vs -4.05% in Sep 2023
Growth in half year ended Sep 2024 is -104.71% vs 278.47% in Sep 2023
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 9.74% vs -12.22% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -148.77% vs 43.91% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 4.03% vs 7.69% in Mar 2025
YoY Growth in year ended Mar 2026 is 273.52% vs -175.62% in Mar 2025